your market intelligence analyst
Search Results
Edit Save
547 results
Cardiovascular News 11/29/2019 10:25
The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing percutaneous coronary intervention (PCI) did not provide mortality benefit and may increase the risk of stroke. However, a new study (CHEETAH) is evaluating whether a next-generation aspiration catheter could lead to improved outcomes. S Jay Mathews (Manatee Memorial Hospital, Bradenton, USA), principal […]. .
Cardiovascular News 11/28/2019 09:42
A significant milestone has been reached for a landmark study into the use of short duration dual anti-platelet therapy (DAPT) in high-bleeding-risk (HBR) patients following stenting procedures, with patient recruitment just completed. A total cohort of approximately 4,500 patients have been randomised into the ambitious investigator-initiated MASTER DAPT “MAnagement of high bleeding risk patients post […]. .
Cardiovascular News 11/27/2019 05:01
Michael Reardon (Houston, USA) talks to BLearning Cardio about the ADAPT tissue technology (Admedus), and the increasing importance of durability as TAVI moves to younger and lower risk patients. Reardon notes that “we would like to have technology that does even better than the surgical valves”, and believes better durability will be the result of “tissue science […]. .
Cardiovascular News 11/26/2019 12:09
The largest trial to date to compare revascularisation with a conservative strategy in patients with stable ischaemic heart disease has found no additional benefit a median of three years after the procedure. Data from the ISCHEMIA trial were presented at a late-breaking trial session at the American Heart Association Scientific Sessions (AHA 2019; 16–18 November, […]. .
Cardiovascular News 11/26/2019 11:54
Preprocedural administration of an oral colchicine load does not reduce the risk of myocardial injury or 30-day major adverse cardiovascular events (MACE) in patients undergoing percutaneous coronary intervention (PCI), according to findings from the Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention (COLCHICINE-PCI) clinical trial.
Cardiovascular News 11/22/2019 08:59
Meril has announced positive data on its Myval Transcatheter Heart Valve System at PCR London Valves 2019 (17–19 November 2019). A follow-up of 100 patients with intermediate- to high-risk for surgical aortic valve replacement (SAVR) in the MyVal-1 study demonstrated high procedural success rate. According to the press release, this is due to the precise […]. .
Cardiovascular News 11/22/2019 08:05
The Revivent transcatheter ventricular enhancement system (Bioventrix) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). The Revivent investigational transcatheter device uses micro-anchors to cinch together the scarred area of the left ventricle to improve heart function. In a press release, Bioventrix explains that the Less Invasive Ventricular Enhancement (LIVE) […]. .
Cardiovascular News 11/19/2019 10:47
An analysis of structural valve deterioration in the PARTNER 2A trial has found that the third generation Sapien 3 transcatheter heart valve (Edwards Lifesciences) has similar durability to surgical valves, with the second generation Sapien XT (also Edwards Lifesciences) demonstrating lower midterm durability than surgery.
Cardiovascular News 11/18/2019 12:02
Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is associated with increased mortality at six years, particularly in patients who are pacemaker dependent. At an abstract session at PCR London Valves 2019 (17–19 November, London, UK), Giuliano Costa (Policlinico – Vittorio Emanuele Hospital, Catania, Italy) presented an algorithm with recommendations on when to […]. .
Cardiovascular News 11/18/2019 11:07
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor System at the 2019 American Heart Association (AHA) Scientific Sessions (16–18 November, Philadelphia, USA). Data were presented by Wilfried Mullens (Hospital Oost-Limburg, Genk, Belgium). The 90-day results from the first-in-human trial confirm the device safety and accuracy of pressure measurements in the right […]. .
Cardiovascular News 11/17/2019 07:53
Over the past few years, the indications for transcatheter aortic valve implantation (TAVI) have expanded from inoperable patients to low-risk patients—meaning that TAVI can now be considered for all aortic stenosis patients, regardless of their surgical risk.1 However, using TAVI in lower risk patients does raise the question of the durability of TAVI valves.
Cardiovascular News 11/15/2019 10:16
The mortality risk for patients with critical limb ischaemia (CLI) has not changed over the last few decades, despite advances in cardiovascular medicine that treat myocardial infarction and stroke, the two biggest causes of death in these patients, Sahil Parikh (New York, USA) tells BLearning Cardio at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las [...]. .
Cardiovascular News 11/14/2019 09:28
Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) system with the aim of using data from the study to supporting regulatory device approval in Japan. The system is used the management of heavily calcified coronary arteries. A press release from the company reports that principal investigator Shigeru Saito (Shonan […]. .
Cardiovascular News 11/14/2019 05:23
A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no between-sex difference in the risk of two-year all-cause mortality or new Q-wave myocardial infarction (MI) following percutaneous coronary intervention (PCI). Published online in JAMA Cardiology, the study also found that the risks of bleeding and haemorrhagic stroke were higher in women than men, […]. .
Cardiovascular News 11/07/2019 05:05
Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implantation (TAVI) device to be used to manage aortic stenosis in low-risk patients. Both Edwards and Medtronic (with its CoreValve range) have FDA approval for their devices to be used for low-risk patients in the USA but, with this new CE […]. .

Information Technologies

IT Markets

Business Issues

Companies - Public

Companies - Venture Funded


Analyst Firms

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications